share_log

Oppenheimer Reiterates Outperform on Achieve Life Sciences, Maintains $18 Price Target

Moomoo 24/7 ·  Apr 1 09:14

Oppenheimer analyst Francois Brisebois reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Outperform and maintains $18 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment